Basic info
Industry
biotechnology research
Sectors
Neurodegeneration
Biotechnology
Therapeutics
Neurodegenerative Disease
Health Diagnostics
Genetics
Pharmaceuticals
Date founded
2015
Funding rounds raised
Total raised
$217M
from 11 investors over 11 rounds
D
Denali Therapeutics raised $130M on August 25, 2016
Investors: ARCH Venture Partners, Alaska Permanent Fund Corporation, Baillie Gifford, F-Prime Capital Partners and Flagship Ventures
D
Denali Therapeutics raised $217M on May 14, 2015
Investors: Alaska Permanent Fund Corporation, Flagship Ventures, F-Prime Capital Partners, Biomatics Capital and ARCH Venture Partners
D
Denali Therapeutics raised undisclosed on January 1, 2009
Investors: GV